John Dennis

6.0k total citations · 1 hit paper
69 papers, 1.8k citations indexed

About

John Dennis is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Molecular Biology. According to data from OpenAlex, John Dennis has authored 69 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Genetics and 11 papers in Molecular Biology. Recurrent topics in John Dennis's work include Diabetes Treatment and Management (24 papers), Diabetes Management and Research (14 papers) and Diabetes and associated disorders (10 papers). John Dennis is often cited by papers focused on Diabetes Treatment and Management (24 papers), Diabetes Management and Research (14 papers) and Diabetes and associated disorders (10 papers). John Dennis collaborates with scholars based in United Kingdom, United States and Denmark. John Dennis's co-authors include Andrew T. Hattersley, Beverley M. Shields, Angus G. Jones, Andrew McGovern, William Henley, Noam Chomsky, Bilal A. Mateen, Sebastian J. Vollmer, Ewan R. Pearson and Rury R. Holman and has published in prestigious journals such as The Lancet, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

John Dennis

65 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data

2019 282 citations John Dennis, Beverley M. Shields et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Dennis United Kingdom	21	712	342	297	277	266	69	1.8k
Ehud Kokia Israel	33	428 0.6×	163 0.5×	414 1.4×	228 0.8×	646 2.4×	69	2.6k
Emma Altobelli Italy	32	268 0.4×	338 1.0×	426 1.4×	317 1.1×	583 2.2×	91	2.5k
Julie Marsh Australia	20	257 0.4×	105 0.3×	329 1.1×	240 0.9×	568 2.1×	120	3.1k
Cornelis Boersma Netherlands	17	228 0.3×	118 0.3×	416 1.4×	142 0.5×	246 0.9×	78	2.5k
Guy Thomas France	16	448 0.6×	207 0.6×	470 1.6×	118 0.4×	236 0.9×	25	1.7k
William D. Finkle United States	14	931 1.3×	630 1.8×	143 0.5×	263 0.9×	205 0.8×	22	2.7k
Aaron M. Secrest United States	21	867 1.2×	509 1.5×	433 1.5×	143 0.5×	197 0.7×	80	2.0k
Suzanne C Freeman United Kingdom	20	458 0.6×	288 0.8×	489 1.6×	89 0.3×	324 1.2×	60	2.0k
Ralph Brinks Germany	24	451 0.6×	246 0.7×	128 0.4×	132 0.5×	371 1.4×	133	1.9k

Countries citing papers authored by John Dennis

Since Specialization

Citations

This map shows the geographic impact of John Dennis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Dennis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Dennis more than expected).

Fields of papers citing papers by John Dennis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Dennis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Dennis. The network helps show where John Dennis may publish in the future.

Co-authorship network of co-authors of John Dennis

This figure shows the co-authorship network connecting the top 25 collaborators of John Dennis. A scholar is included among the top collaborators of John Dennis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Dennis. John Dennis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Young, Katherine, Andrew McGovern, Beverley M. Shields, et al.. (2025). Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection. Diabetologia. 69(2). 374–385. 1 indexed citations

Young, Katherine, Bilal A. Mateen, Ewan R. Pearson, et al.. (2025). Evaluating prediction of short‐term tolerability of five type 2 diabetes drug classes using routine clinical features: UK population‐based study. Diabetes Obesity and Metabolism. 27(8). 4320–4329. 2 indexed citations

Zaharia, Oana‐Patricia, Klaus Straßburger, John Dennis, et al.. (2025). Recognising, quantifying and accounting for classification uncertainty in type 2 diabetes subtypes. Diabetologia. 68(10). 2139–2150. 2 indexed citations

Young, Katherine, Nicholas J. Thomas, Bilal A. Mateen, et al.. (2024). Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study. BMJ Open. 14(1). e078135–e078135. 6 indexed citations

Thomas, Nicholas J., Robert Challen, Angus G. Jones, et al.. (2024). Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach. Diabetologia. 67(9). 1817–1827. 9 indexed citations

Young, Katherine, Anand Thakarakkattil Narayanan Nair, Andrew McGovern, et al.. (2024). Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Diabetologia. 67(5). 822–836. 12 indexed citations

Shields, Beverley M., John Dennis, Fiona C Warren, et al.. (2022). Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study. Nature Medicine. 29(2). 376–383. 27 indexed citations

Young, Katherine, Andrew McGovern, Inês Barroso, et al.. (2022). The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis. Diabetologia. 66(2). 300–309. 4 indexed citations

Thomas, Nicholas J., Andrew McGovern, Katherine Young, et al.. (2022). Identifying type 1 and 2 diabetes in research datasets where classification biomarkers are unavailable: assessing the accuracy of published approaches. Journal of Clinical Epidemiology. 153. 34–44. 14 indexed citations

10.

Lusignan, Simon de, Helen Alexander, John Dennis, et al.. (2022). Atopic dermatitis and risk of autoimmune conditions: Population-based cohort study. Journal of Allergy and Clinical Immunology. 150(3). 709–713. 40 indexed citations

11.

Nair, Anand Thakarakkattil Narayanan, Agata Wesolowska‐Andersen, Caroline Brorsson, et al.. (2022). Heterogeneity in phenotype, disease progression and drug response in type 2 diabetes. Nature Medicine. 28(5). 982–988. 72 indexed citations

12.

Mateen, Bilal A., John Dennis, Andrew J. Duncan, et al.. (2021). Hospital bed capacity and usage across secondary healthcare providers in England during the first wave of the COVID-19 pandemic: a descriptive analysis. BMJ Open. 11(1). e042945–e042945. 26 indexed citations

13.

McGovern, Andrew, Nicholas J. Thomas, Sebastian J. Vollmer, et al.. (2021). The disproportionate excess mortality risk of COVID-19 in younger people with diabetes warrants vaccination prioritisation. Diabetologia. 64(5). 1184–1186. 14 indexed citations

14.

Dennis, John, et al.. (2021). A national retrospective study of the association between serious operational problems and COVID-19 specific intensive care mortality risk. PLoS ONE. 16(7). e0255377–e0255377. 2 indexed citations

15.

Thomas, Nicholas J., John Dennis, Seth A. Sharp, et al.. (2021). DR15-DQ6 remains dominantly protective against type 1 diabetes throughout the first five decades of life. Diabetologia. 64(10). 2258–2265. 17 indexed citations

16.

Dennis, John, Andrew McGovern, Sebastian J. Vollmer, & Bilal A. Mateen. (2020). Improving Survival of Critical Care Patients With Coronavirus Disease 2019 in England: A National Cohort Study, March to June 2020*. Critical Care Medicine. 49(2). 209–214. 101 indexed citations

17.

McGovern, Andrew, Michael A. Hogg, Beverley M. Shields, et al.. (2020). Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation. BMJ Open Diabetes Research & Care. 8(1). e001238–e001238. 62 indexed citations

18.

Dennis, John. (2020). Precision Medicine in Type 2 Diabetes: Using Individualized Prediction Models to Optimize Selection of Treatment. Diabetes. 69(10). 2075–2085. 76 indexed citations

19.

Dennis, John, William Henley, Andrew McGovern, et al.. (2019). Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010–2017. Diabetes Obesity and Metabolism. 21(7). 1576–1584. 68 indexed citations

20.

Markus, Hugh S., Susanna C. Larsson, John Dennis, et al.. (2019). Vertebral artery stenting to prevent recurrent stroke in symptomatic vertebral artery stenosis: the VIST RCT. Health Technology Assessment. 23(41). 1–30. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact